UnitedHealth elects all nine director nominees at 2026 annual meeting

4. Shareholder proposal requesting the adoption of a policy to require any board chair to be independent. The shareholder proposal was not approved based upon the following votes: For Against Abstain Broker Non-Votes % of Votes For* 137,347,215 537,634,392 3,348,847 89,736,263 20.24%

1. Election of Directors. The nine directors were elected at the Annual Meeting for a one-year term based upon the following votes: Director Nominee For Against Abstain Broker Non-Votes % of Votes For* Charles Baker 606,637,150 69,792,687 1,900,617 89,736,263 89.68% Timothy Flynn 646,534,589 31,180,999 614,866 89,736,263 95.39% Paul Garcia 657,046,651 20,686,201 597,602 89,736,263 96.94% Kristen Gil 670,734,403 7,012,293 583,758 89,736,263 98.96% Scott Gottlieb, M.D. 630,040,056 47,696,583 593,815 89,736,263 92.96% Stephen Hemsley 646,655,805 28,777,298 2,897,351 89,736,263 95.73% F. William McNabb III 658,345,360 19,413,024 572,070 89,736,263 97.13% Valerie Montgomery Rice, M.D. 660,235,862 17,561,570 533,022 89,736,263 97.40% John Noseworthy, M.D. 665,000,847 12,755,561 574,046 89,736,263 98.11%

2. Non-binding advisory vote on executive compensation. The Company’s executive compensation was approved by a non-binding advisory vote based upon the following votes: For Against Abstain Broker Non-Votes % of Votes For* 559,434,838 117,731,618 1,163,998 89,736,263 82.74%

3. Ratification of the appointment of Deloitte & Touche LLP. The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified based upon the following votes: For Against Abstain % of Votes For* 729,713,547 37,552,773 800,397 95.00%